治疗SARS-CoV-2感染和COVID-19的有前途的候选药物评价

N. Hentig
{"title":"治疗SARS-CoV-2感染和COVID-19的有前途的候选药物评价","authors":"N. Hentig","doi":"10.35248/19485964.20.12.198","DOIUrl":null,"url":null,"abstract":"Since November 2019 the severe acute respiratory syndrome (SARS) or coronavirus disease 2019 (Covid 19) caused by the new human corona virus (HCoV), is spreading around the world, causing a major loss of lives.","PeriodicalId":15020,"journal":{"name":"Journal of Antivirals & Antiretrovirals","volume":"94 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Appraisal of Promising Repurposed Drug Candidates for the Treatment of SARS-CoV-2 Infection and COVID-19\",\"authors\":\"N. Hentig\",\"doi\":\"10.35248/19485964.20.12.198\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since November 2019 the severe acute respiratory syndrome (SARS) or coronavirus disease 2019 (Covid 19) caused by the new human corona virus (HCoV), is spreading around the world, causing a major loss of lives.\",\"PeriodicalId\":15020,\"journal\":{\"name\":\"Journal of Antivirals & Antiretrovirals\",\"volume\":\"94 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Antivirals & Antiretrovirals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/19485964.20.12.198\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antivirals & Antiretrovirals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/19485964.20.12.198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

自2019年11月以来,由新型人类冠状病毒(HCoV)引起的严重急性呼吸系统综合症(SARS)或2019年冠状病毒病(Covid - 19)在世界各地蔓延,造成重大生命损失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Appraisal of Promising Repurposed Drug Candidates for the Treatment of SARS-CoV-2 Infection and COVID-19
Since November 2019 the severe acute respiratory syndrome (SARS) or coronavirus disease 2019 (Covid 19) caused by the new human corona virus (HCoV), is spreading around the world, causing a major loss of lives.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信